SNP information rs1799978

Research and publications:

  17105675   The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients.

  18305461   Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety.

  18330705   Physiogenomic analysis of localized FMRI brain activity in schizophrenia.

  18855532   Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia.

  19156168   Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.

  19373123   Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.

  19512960   Genetic diagnostics of functional variants of the human dopamine D2 receptor gene.

  19968402   Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants.

  20736885   PharmGKB summary: dopamine receptor D2.

  21162693   Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.

  21178390   Associations between DRDs and schizophrenia in a Korean population: multi-stage association analyses.

  21906503   Different phenotypic and genotypic presentations in alcohol dependence: age at onset matters.

  21948099   Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?

  22424959   DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience.

  22963930   Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent.

  22992668   Pharmacogenomics knowledge for personalized medicine.

  23828101   Impulsivity and genetic variants in DRD2 and ANKK1 moderate longitudinal associations between sleep problems and overweight from ages 5 to 11.

  24782743   Association of COMT and COMT-DRD2 interaction with creative potential.

  24944790   Screening for 392 polymorphisms in 141 pharmacogenes.

  26044620   Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction.

  26437921   Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study.

  26880915   Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents.

  27217270   Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.

  27933030   The Association of DRD2 with Insight Problem Solving.

  28470827   Pharmacogenomics and Efficacy of Risperidone Long-Term Treatment in Thai Autistic Children and Adolescents.

  29495204   [Association between DRD2 gene polymorphisms and the dosage used on methadone maintenance treatment program].

  29623639   Pharmacogenetics of Opioid Use Disorder Treatment.

  29716536   Dopamine D2 receptor gene polymorphisms and externalizing behaviors in children and adolescents.

  29966133   Association between Polymorphisms of the DRD2 and ANKK1 Genes and Suicide Attempt: A Preliminary Case-Control Study in a Mexican Population.

  30093869   Biological Predictors of Clozapine Response: A Systematic Review.

  30103286   Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis.

  30607769   Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population.

  31129315   Systematic Review and Meta-Analysis of Genetic Risk of Developing Chronic Postsurgical Pain.

  31744450   Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine.

  32992097   Association of the genetic polymorphisms of metabolizing enzymes, transporters, target receptors and their interactions with treatment response to olanzapine in chinese han schizophrenia patients.

  33519226   Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon.

  35140610   Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies.